DE602004014913D1 - Verbesserte osteoinduktive materialien - Google Patents

Verbesserte osteoinduktive materialien

Info

Publication number
DE602004014913D1
DE602004014913D1 DE602004014913T DE602004014913T DE602004014913D1 DE 602004014913 D1 DE602004014913 D1 DE 602004014913D1 DE 602004014913 T DE602004014913 T DE 602004014913T DE 602004014913 T DE602004014913 T DE 602004014913T DE 602004014913 D1 DE602004014913 D1 DE 602004014913D1
Authority
DE
Germany
Prior art keywords
matrix material
morphogenetic protein
osteoinductive materials
protein
improved osteoinductive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004014913T
Other languages
English (en)
Inventor
Jens Pohl
Rolf Bechtold
Michael Kruse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH
Original Assignee
Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH filed Critical Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH
Publication of DE602004014913D1 publication Critical patent/DE602004014913D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
DE602004014913T 2003-03-28 2004-03-26 Verbesserte osteoinduktive materialien Expired - Lifetime DE602004014913D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03007141A EP1462126A1 (de) 2003-03-28 2003-03-28 Verbesserte osteoinduktive Materialien
PCT/EP2004/003238 WO2004084965A2 (en) 2003-03-28 2004-03-26 Improved osteoinductive materials

Publications (1)

Publication Number Publication Date
DE602004014913D1 true DE602004014913D1 (de) 2008-08-21

Family

ID=32798932

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004014913T Expired - Lifetime DE602004014913D1 (de) 2003-03-28 2004-03-26 Verbesserte osteoinduktive materialien

Country Status (14)

Country Link
US (2) US7485617B1 (de)
EP (2) EP1462126A1 (de)
JP (1) JP4863868B2 (de)
AT (1) ATE400308T1 (de)
AU (1) AU2004224768B2 (de)
CA (1) CA2519174C (de)
CY (1) CY1108386T1 (de)
DE (1) DE602004014913D1 (de)
DK (1) DK1608414T3 (de)
ES (1) ES2305757T3 (de)
PL (1) PL1608414T3 (de)
PT (1) PT1608414E (de)
SI (1) SI1608414T1 (de)
WO (1) WO2004084965A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
EP1578348A4 (de) * 2002-02-08 2011-03-16 Wyeth Llc Formulierung mit bioaktiven mitteln und verwendungsverfahren dafür
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
EP1462126A1 (de) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Verbesserte osteoinduktive Materialien
EP1880731A1 (de) * 2006-07-18 2008-01-23 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Menschlicher Wachstums und Differenzierungsfaktor GDF-5
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
DE102006060958A1 (de) 2006-12-20 2008-06-26 Jennissen, Herbert P., Prof. Dr. Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US20100047299A1 (en) * 2007-01-25 2010-02-25 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Use of gdf-5 for the improvement or maintenance of dermal appearance
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
DE102007051914A1 (de) * 2007-10-29 2009-05-07 Herbert Prof. Dr. Jennissen Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
CA2720845A1 (en) 2008-04-14 2009-10-22 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered gdf-5 formulations
WO2010098421A1 (ja) * 2009-02-27 2010-09-02 株式会社オステオファーマ 改善された保存安定性を有する組換えヒト骨形成蛋白質
US8609409B2 (en) 2009-06-04 2013-12-17 Clemson University Methods and compositions for cell culture platform
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
AU2011284657B2 (en) 2010-07-30 2013-11-14 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Drug delivery devices and growth factor formulations for accelerated wound healing
JP2013542837A (ja) 2010-11-15 2013-11-28 ジンマー オーソバイオロジクス，インコーポレイティド 骨空隙充填剤
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
EP2537538A1 (de) 2011-06-22 2012-12-26 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH Bioresorbierbarer Wundverband
KR20240005209A (ko) 2014-12-09 2024-01-11 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 신종 상처 치료기구
US11324806B2 (en) * 2018-10-19 2022-05-10 Warsaw Orthopedic, Inc. Sustained delivery of a growth differentiation factor
CN111803718B (zh) * 2020-07-02 2022-02-25 西安交通大学医学院第二附属医院 一种抗纤维化药物缓释涂层及其制备方法
CN114432502B (zh) * 2021-12-31 2023-02-03 中山大学附属第八医院（深圳福田） 一种负载op3-4多肽、抗cxcl9抗体的水凝胶及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121043A1 (de) * 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
WO1994015653A1 (en) * 1993-01-12 1994-07-21 Genentech, Inc. Tgf-beta formulation for inducing bone growth
JPH0788174A (ja) * 1993-09-28 1995-04-04 Yamanouchi Pharmaceut Co Ltd 骨形成用移植体
EP1074620A1 (de) * 1999-08-06 2001-02-07 HyGene AG Monomer Protein der TGF-beta Familie
JPH10243996A (ja) * 1997-03-07 1998-09-14 Kagaku Gijutsu Shinko Jigyodan 硬組織石灰化促進用生体材料
WO2000048550A2 (en) * 1999-02-16 2000-08-24 Sulzer Biologics, Inc. Device and method for regeneration and repair of cartilage lesions
ES2223965T3 (es) * 2000-12-06 2005-03-01 Astra Tech Ab Protesis e implantes medicos revestidos con hidruros metalicos y biomoleculas que tienen biocompatibilidad mejorada.
BR0214275A (pt) * 2001-11-19 2004-09-21 Scil Technology Gmbh Dispositivo tendo propriedades osteocondutora e osteoindutora
EP1462126A1 (de) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Verbesserte osteoinduktive Materialien

Also Published As

Publication number Publication date
PL1608414T3 (pl) 2009-02-27
CA2519174C (en) 2012-05-15
WO2004084965A2 (en) 2004-10-07
US8163694B2 (en) 2012-04-24
JP4863868B2 (ja) 2012-01-25
JP2006521135A (ja) 2006-09-21
DK1608414T3 (da) 2008-11-10
ATE400308T1 (de) 2008-07-15
PT1608414E (pt) 2008-10-21
AU2004224768A1 (en) 2004-10-07
EP1608414A2 (de) 2005-12-28
WO2004084965A3 (en) 2004-11-25
EP1608414B1 (de) 2008-07-09
SI1608414T1 (sl) 2008-10-31
EP1462126A1 (de) 2004-09-29
CY1108386T1 (el) 2014-02-12
CA2519174A1 (en) 2004-10-07
ES2305757T3 (es) 2008-11-01
US7485617B1 (en) 2009-02-03
AU2004224768B2 (en) 2008-05-22
US20090155366A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
ATE400308T1 (de) Verbesserte osteoinduktive materialien
DE602004031114D1 (de) Stickstoffhaltige heteroarylverbindungen und deren verwendungen zur erhoehung des gehaltes von endogenem erythropoietin
DE60031441D1 (de) Immobilisierung von proteinen mit hilfe eines polypeptidsegments
DE60326259D1 (de) Neue fructosylpeptidoxidase und deren nutzung
ATE396738T1 (de) Verwendung von glp-2-peptiden
NO20043257L (no) Innkapslede bindingsproteiner som biosensorer
EA199900725A1 (ru) Синергетические комбинации сульфонилмочевины и глитазона при лечении диабета
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
DE69832293D1 (de) Zubereitungen zur abgabe von negativ geladenen molekülen
DK0967176T3 (da) Agglomerater på basis af aktivt kul, deres fremstillingsmåde og anvendelse som adsorptionsmidler
ATE462970T1 (de) Screeningverfahren mit porösen mikrokügelchen und zusammensetzungen
NO992116D0 (no) Terapeutiske og diagnostiske midler som er i stand til Õ modulere responderbarhet overfor cytokiner
ATE317127T1 (de) Methode zur stabilisierung von plättchen
DE60129137D1 (de) Modulierung durch il-tif/interleukin-21
DE50015781D1 (de) Deren verwendung zum transport von molekülen über biologische membranen
ATE346859T1 (de) Zusammensetzung zum zellspezifischen transfer von wirkstoffen
DE50208261D1 (de) Verfahren zur verringerung einer adsorptionsneigung von molekülen oder biologischen zellen an einer materialoberfläche
EP2292666A3 (de) Neoplasma-spezifische Antikörper und deren Verwendungen
WO2006106363A3 (en) Fluid disinfection apparatus and system
EP0987549A3 (de) Testsystem zur Charakterisierung der Verträglichkeit von biologisch aktiven Substanzen und Polyvinylpyrrolidon
ES2169890T3 (es) 3-mercapto-2-alquilalcan-1-oles y su utilizacion como sustancia olorosa o aromatica.
DE50214446D1 (de) Neue verwendung von lungensurfactant
DK1083224T3 (da) Apoptin-associerende protein
Sobchenko et al. The cellular wall role of different mosses species in Cs 137 sorption; Rol'kletochnoj stenki v sorbtsii Cs 137 razlichnymi vidami zelenykh mkhov

Legal Events

Date Code Title Description
8364 No opposition during term of opposition